Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Axsome Therapeutics (AXSM) Q3 2023 Earnings Call Transcript


Image source: The Motley Fool.

Axsome Therapeutics (NASDAQ: AXSM)
Q3 2023 Earnings Call
Nov 06, 2023, 8:00 a.m. ET

Operator

Continue reading


Source Fool.com

Axsome Therapeutics Inc Stock

€69.50
0.660%
Axsome Therapeutics Inc gained 0.660% compared to yesterday.
The community is currently still undecided about Axsome Therapeutics Inc with 2 Buy predictions and 0 Sell predictions.
As a result the target price of 100 € shows a positive potential of 43.88% compared to the current price of 69.5 € for Axsome Therapeutics Inc.
Like: 0
Share

Comments